TheProfitWatch

BDTX - Black Diamond Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
3.87 -0.06 (-1.53%) 0.0 (-0.13%) 0.0 (-0.13%) 0.0 (-0.13%) -0.12 (-3.08%) 0.06 (1.6%) 0.0 (0.0%) 0.01 (0.27%)

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.19
Diluted EPS:
-0.19
Basic P/E:
-20.0526
Diluted P/E:
-20.0526
RSI(14) 1m:
80.0
VWAP:
3.81
RVol:

Events

Period Kind Movement Occurred At

Related News